221 related articles for article (PubMed ID: 28640083)
1. Clinical significance of plasma D-dimer in ovarian cancer: A meta-analysis.
Wu J; Fu Z; Liu G; Xu P; Xu J; Jia X
Medicine (Baltimore); 2017 Jun; 96(25):e7062. PubMed ID: 28640083
[TBL] [Abstract][Full Text] [Related]
2. Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.
Yamada Y; Kawaguchi R; Iwai K; Niiro E; Morioka S; Tanase Y; Kobayashi H
J Obstet Gynaecol; 2020 Jan; 40(1):102-106. PubMed ID: 31335252
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
Man YN; Wang YN; Hao J; Liu X; Liu C; Zhu C; Wu XZ
Int J Gynecol Cancer; 2015 Jan; 25(1):24-32. PubMed ID: 25347092
[TBL] [Abstract][Full Text] [Related]
4. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.
Liu P; Wang Y; Tong L; Xu Y; Zhang W; Guo Z; Ni H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1163-71. PubMed ID: 26542279
[TBL] [Abstract][Full Text] [Related]
5. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis.
Li W; Tang Y; Song Y; Chen SH; Sisliyan N; Ni M; Zhang H; Zeng Q; Hou B; Xie X; Chang D
Cell Physiol Biochem; 2018; 45(4):1663-1676. PubMed ID: 29490291
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis.
Li J; Wang Y; Li J; Che G
Technol Cancer Res Treat; 2021; 20():1533033821989822. PubMed ID: 33563114
[TBL] [Abstract][Full Text] [Related]
8. The association of D-dimer with clinicopathological features of breast cancer and its usefulness in differential diagnosis: A systematic review and meta-analysis.
Lu Y; Zhang L; Zhang Q; Zhang Y; Chen D; Lou J; Jiang J; Ren C
PLoS One; 2019; 14(9):e0221374. PubMed ID: 31487295
[TBL] [Abstract][Full Text] [Related]
9. The association between fibrinogen, von Willebrand Factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer.
Koh SC; Khalil R; Lim FK; Ilancheran A; Choolani M
Clin Appl Thromb Hemost; 2006 Jan; 12(1):3-8. PubMed ID: 16444428
[TBL] [Abstract][Full Text] [Related]
10. High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.
Sakurai M; Satoh T; Matsumoto K; Michikami H; Nakamura Y; Nakao S; Ochi H; Onuki M; Minaguchi T; Yoshikawa H
Int J Gynecol Cancer; 2015 May; 25(4):593-8. PubMed ID: 25756402
[TBL] [Abstract][Full Text] [Related]
11. Plasma D-dimer measurement as a marker of gynecologic tumors: comparison with Ca 125.
Rella C; Coviello M; De Frenza N; Falco G; Chiuri E; Colavito P; Quaranata M; De Leonardis A
Tumori; 1993 Oct; 79(5):347-51. PubMed ID: 8116080
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis.
Lin Y; Liu Z; Qiu Y; Zhang J; Wu H; Liang R; Chen G; Qin G; Li Y; Zou D
Eur J Surg Oncol; 2018 Oct; 44(10):1494-1503. PubMed ID: 30100361
[TBL] [Abstract][Full Text] [Related]
13. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis.
Chen L; Wang X; Shu J; Xu S; Wu Q; Yu Y
Int J Gynaecol Obstet; 2019 Nov; 147(2):212-218. PubMed ID: 31469423
[TBL] [Abstract][Full Text] [Related]
15. High pretreatment plasma D-dimer levels are related to shorter overall survival in endometrial carcinoma.
Nakamura K; Nakayama K; Ishikawa M; Katagiri H; Minamoto T; Ishibashi T; Ishikawa N; Sato E; Sanuki K; Yamashita H; Komatsu-Fujii T; Kyo S
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():89-93. PubMed ID: 27085144
[TBL] [Abstract][Full Text] [Related]
16. Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinoma.
Tamura R; Yoshihara K; Matsuo K; Yachida N; Miyoshi A; Takahashi K; Sugino K; Yamaguchi M; Mori Y; Suda K; Ishiguro T; Okuda S; Motoyama T; Nakaoka H; Kikuchi A; Ueda Y; Inoue I; Enomoto T
Gynecol Oncol; 2021 Nov; 163(2):327-333. PubMed ID: 34452748
[TBL] [Abstract][Full Text] [Related]
17. [The role of D-dimer in diagnosis of ovarian cancer].
Kanayama N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):485-8. PubMed ID: 2056222
[TBL] [Abstract][Full Text] [Related]
18. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
[TBL] [Abstract][Full Text] [Related]
19. The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis.
Ma M; Cao R; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
J Cardiothorac Surg; 2021 Aug; 16(1):243. PubMed ID: 34454552
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
Koh SC; Tham KF; Razvi K; Oei PL; Lim FK; Roy AC; Prasad RN
Clin Appl Thromb Hemost; 2001 Apr; 7(2):141-8. PubMed ID: 11292192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]